In addition to the indication that PGE2 antagonism may increase the efficacy of BCG in early stages of the BlCa, our data suggest that the same combination may also enhance the effectiveness of PD-1/PD-L1 blockade in patients with muscle invasive or metastatic BlCa. Here, CD274 is linked to bladder transitional cell carcinoma.